Novartis has appointed Marc Boutin as Global Head of Patient Engagement & Advocacy. He will join Novartis no later than November 1, 2020.
Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.